-
Type i interferon biomarker in idiopathic inflammatory myopathies: Associations of Siglec-1 with disease activity and treatment response
Kamperman, R. G., Veldkamp, S. R., Evers, S. W., Lim, J., van Schaik, I., van Royen-Kerkhof, A., van Wijk, F., van der Kooi, A. J., Jansen, M. & Raaphorst, J., 1 May 2025, In: Nature Clinical Practice Rheumatology. 64, 5, p. 2979-2986 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study
Dutch Myositis Network, 1 Sept 2023, In: Journal of autoimmunity. 139, 103081.Research output: Contribution to journal › Article* › Academic › peer-review
-
Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trial
Kamperman, R. G., Bogaards, J. A., Evers, S. W., Walter, H. A. W., de Visser, M., de Borgie, C., Colen - de Koning, J. C. A., Verhamme, C., Maas, M., Eftimov, F., van Schaik, I. N., van der Kooi, A. J. & Raaphorst, J., 10 Jul 2023, In: BMJ open. 13, 7, e067435.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
